{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:40:24Z","timestamp":1790959224594,"version":"4.1.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.ijpharm.2025.125293","type":"journal-article","created":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T19:11:04Z","timestamp":1738005064000},"page":"125293","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Disulfiram-Loaded PLGA nanoparticles modified with a Phenyl borate chitosan Conjugate enhance hepatic carcinoma treatment"],"prefix":"10.1016","volume":"671","author":[{"given":"Yanyi","family":"Feng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simiao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaijun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Yun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dengyuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinxin","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chutong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingchun","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2025.125293_b0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.matlet.2021.131114","article-title":"Tuning the surface charge properties of chitosan nanoparticles","volume":"308","author":"Athavale","year":"2022","journal-title":"Materials Letters"},{"key":"10.1016\/j.ijpharm.2025.125293_b0010","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.ijbiomac.2016.11.098","article-title":"Preparation and characterization of polymeric nanoparticles surface modified with chitosan for target treatment of colorectal cancer","volume":"95","author":"Badran","year":"2017","journal-title":"International Journal of Biological Macromolecules"},{"key":"10.1016\/j.ijpharm.2025.125293_b0015","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ijpharm.2018.12.051","article-title":"Integrating the drug, disulfiram into the vitamin E-TPGS-modified PEGylated nanostructured lipid carriers to synergize its repurposing for anti-cancer therapy of solid tumors","volume":"557","author":"Banerjee","year":"2019","journal-title":"International Journal of Pharmaceutics"},{"key":"10.1016\/j.ijpharm.2025.125293_b0020","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1080\/17425247.2023.2190581","article-title":"Clinical, pharmacological, and formulation evaluation of disulfiram in the treatment of glioblastoma - a systematic literature review","volume":"20","author":"Benk\u0151","year":"2023","journal-title":"Expert Opinion on Drug Delivery"},{"key":"10.1016\/j.ijpharm.2025.125293_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124187","article-title":"Cyclodextrin encapsulation enabling the anticancer repositioning of disulfiram: Preparation, analytical and in vitro biological characterization of the inclusion complexes","volume":"657","author":"Benk\u0151","year":"2024","journal-title":"International Journal of Pharmaceutics"},{"key":"10.1016\/j.ijpharm.2025.125293_b0030","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1021\/acs.nanolett.8b04645","article-title":"Reversible Shielding between Dual Ligands for Enhanced Tumor Accumulation of ZnPc-Loaded Micelles","volume":"19","author":"Cao","year":"2019","journal-title":"Nano Lett."},{"key":"10.1016\/j.ijpharm.2025.125293_b0035","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature01322","article-title":"Inflammation and cancer","volume":"420","author":"Coussens","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.ijpharm.2025.125293_b0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioadv.2022.213038","article-title":"Folic acid-modified disulfiram\/Zn-IRMOF3 nanoparticles for oral cancer therapy by inhibiting ALDH1A1+ cancer stem cells","volume":"139","author":"Cui","year":"2022","journal-title":"Biomaterials Advances"},{"key":"10.1016\/j.ijpharm.2025.125293_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.124370","article-title":"Metal-organic framework decorated with glycyrrhetinic acid conjugated chitosan as a pH-responsive nanocarrier for targeted drug delivery","volume":"240","author":"Cui","year":"2023","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.ijpharm.2025.125293_b0050","doi-asserted-by":"crossref","first-page":"15501","DOI":"10.1021\/ja406406h","article-title":"Phenylboronic Acid-Installed Polymeric Micelles for Targeting Sialylated Epitopes in Solid Tumors","volume":"135","author":"Deshayes","year":"2013","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ijpharm.2025.125293_b0055","first-page":"671","article-title":"Diagnostic value of serologic markers in differentiating primary hepatocellular carcinoma from metastasis","volume":"32","author":"Dong","year":"2019","journal-title":"Heilongjiang Medicine Journal"},{"key":"10.1016\/j.ijpharm.2025.125293_b0060","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/BF01877380","article-title":"Sodium ditiocarb as adjuvant immunotherapy for high risk breast cancer: A randomized study","volume":"6","author":"Dufour","year":"1993","journal-title":"Biotherapy"},{"key":"10.1016\/j.ijpharm.2025.125293_b0065","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.3390\/nano14131133","article-title":"Exploring Disulfiram\u2019s Anticancer Potential: PLGA Nano-Carriers for Prolonged Drug Delivery and Potential Improved Therapeutic Efficacy","volume":"14","author":"Dumbuya","year":"2024","journal-title":"Nanomaterials (basel)"},{"key":"10.1016\/j.ijpharm.2025.125293_b0070","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s13065-022-00888-w","article-title":"Synthesis, characterization, and cytotoxicity of doxorubicin-loaded polycaprolactone nanocapsules as controlled anti-hepatocellular carcinoma drug release system","volume":"16","author":"Fahmi","year":"2022","journal-title":"BMC Chem"},{"key":"10.1016\/j.ijpharm.2025.125293_b0075","series-title":"Sialic Acids and Sialoglycoconjugates in the Biology of Life, Health and Disease","first-page":"211","article-title":"Chapter 8 - Sialic acids and sialoglycoconjugates in cancer","author":"Ghosh","year":"2020"},{"key":"10.1016\/j.ijpharm.2025.125293_b0080","first-page":"312","article-title":"Protective Effect of Polysaccharide Extracted from Rehmanniae Preparata on Adriamycin-induced Myelosuppression and Immunologic Injury in Mice","volume":"38","author":"Guan","year":"2014","journal-title":"Journal of Zhejiang Chinese Medical University"},{"key":"10.1016\/j.ijpharm.2025.125293_b0085","doi-asserted-by":"crossref","first-page":"5419","DOI":"10.2147\/IJN.S168808","article-title":"Main trends of immune effects triggered by nanomedicines in preclinical studies","volume":"13","author":"Halamoda-Kenzaoui","year":"2018","journal-title":"IJN"},{"key":"10.1016\/j.ijpharm.2025.125293_b0090","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.jconrel.2021.06.016","article-title":"Methodological needs in the quality and safety characterisation of nanotechnology-based health products: Priorities for method development and standardisation","volume":"336","author":"Halamoda-Kenzaoui","year":"2021","journal-title":"Journal of Controlled Release"},{"key":"10.1016\/j.ijpharm.2025.125293_b0095","article-title":"Nanotherapeutics approaches to overcome P-glycoprotein-mediated multi-drug resistance in cancer","volume":"40","author":"Halder","year":"2022","journal-title":"Nanomedicine: Nanotechnology, Biology and Medicine"},{"key":"10.1016\/j.ijpharm.2025.125293_b0100","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of Cancer: The Next Generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.ijpharm.2025.125293_b0105","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.arcmed.2019.05.013","article-title":"Determination of Salivary Sialic Acid Through Nanotechnology: A Useful Biomarker for the Screening of Breast Cancer","volume":"50","author":"Hern\u00e1ndez-Arteaga","year":"2019","journal-title":"Archives of Medical Research"},{"key":"10.1016\/j.ijpharm.2025.125293_b0110","first-page":"1641","article-title":"Anti-proliferative and apoptosis-triggering potential of disulfiram and disulfiram-loaded polysorbate 80-stabilized PLGA nanoparticles on hepatocellular carcinoma Hep3B cell line. Nanomedicine: Nanotechnology","volume":"12","author":"Hoda","year":"2016","journal-title":"Biology and Medicine"},{"key":"10.1016\/j.ijpharm.2025.125293_b0115","first-page":"1019","article-title":"Research Progress of Nanometer Drug Delivery Systems of Disulfiram for Tumor Therapy","volume":"52","author":"Huang","year":"2021","journal-title":"Chinese Journal of Pharmaceuticals"},{"key":"10.1016\/j.ijpharm.2025.125293_b0120","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/jcp.24221","article-title":"Regulation of intracellular pH in cancer cell lines under normoxia and hypoxia","volume":"228","author":"Hulikova","year":"2013","journal-title":"Journal of Cellular Physiology"},{"key":"10.1016\/j.ijpharm.2025.125293_b0125","first-page":"565","article-title":"Preparation of disulfiram nanosuspension and ex vivo anti-breast cancer study","volume":"54","author":"Ji","year":"2019","journal-title":"Acta Pharmaceutica Sinica"},{"key":"10.1016\/j.ijpharm.2025.125293_b0130","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.2174\/1871520615666160504095040","article-title":"Disulfiram\u2019s Anticancer Activity: Evidence and Mechanisms","volume":"16","author":"Jiao","year":"2016","journal-title":"Anti-Cancer Agents in Medicinal Chemistry"},{"key":"10.1016\/j.ijpharm.2025.125293_b0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.121335","article-title":"Leveraging disulfiram to treat cancer: Mechanisms of action, delivery strategies, and treatment regimens","volume":"281","author":"Lu","year":"2022","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijpharm.2025.125293_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2022.115968","article-title":"Aidi injection enhances the anti-tumor impact of doxorubicin in H22 tumor-containing mice","volume":"303","author":"Lu","year":"2023","journal-title":"Journal of Ethnopharmacology"},{"key":"10.1016\/j.ijpharm.2025.125293_b0145","first-page":"803","article-title":"Progress on Application of Folate-Chitosan Conjugates and Derivatives in Drug-Loaded Systems","volume":"42","author":"Lu","year":"2020","journal-title":"Chemical Reagents"},{"key":"10.1016\/j.ijpharm.2025.125293_b0150","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.2174\/1871520621666210112122334","article-title":"Polymers Based on Phenyl Boric Acid in Tumor-Targeted Therapy","volume":"21","author":"Luo","year":"2021","journal-title":"Anticancer Agents Med Chem"},{"key":"10.1016\/j.ijpharm.2025.125293_b0155","first-page":"71","article-title":"Research progress in anti-tumor effects and mechanisms of disulfiram","volume":"36","author":"Luo","year":"2022","journal-title":"Chinese Journal of Pharmacology and Toxicology"},{"key":"10.1016\/j.ijpharm.2025.125293_b0160","first-page":"2110","article-title":"Comparative study of serum indexes before and after cancer incidence in patients with liver cancer","volume":"27","author":"Luo","year":"2016","journal-title":"Hainan Medical Journal"},{"key":"10.1016\/j.ijpharm.2025.125293_b0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2022.109445","article-title":"Can the prognosis of individual patients with nasopharyngeal carcinoma be predicted using a routine blood test at admission?","volume":"179","author":"Mao","year":"2023","journal-title":"Radiotherapy and Oncology"},{"key":"10.1016\/j.ijpharm.2025.125293_b0170","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s11095-018-2370-0","article-title":"A Smart Paclitaxel-Disulfiram Nanococrystals for Efficient MDR Reversal and Enhanced Apoptosis","volume":"35","author":"Mohammad","year":"2018","journal-title":"Pharm Res"},{"key":"10.1016\/j.ijpharm.2025.125293_b0175","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.ejpb.2016.11.032","article-title":"Development and characterisation of disulfiram-loaded PLGA nanoparticles for the treatment of non-small cell lung cancer","volume":"112","author":"Najlah","year":"2017","journal-title":"European Journal of Pharmaceutics and Biopharmaceutics"},{"key":"10.1016\/j.ijpharm.2025.125293_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.adcanc.2023.100089","article-title":"Alpha mangostin inhibits proliferation, migration, and invasion of human breast cancer cells via STAT3 inhibition","volume":"7","author":"Nalla","year":"2023","journal-title":"Advances in Cancer Biology - Metastasis"},{"key":"10.1016\/j.ijpharm.2025.125293_b0185","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.2217\/nnm-2018-0490","article-title":"Ligand Decorated Chitosan as an Advanced Nanocarrier for Targeted Delivery: A Critical Review","volume":"14","author":"Qindeel","year":"2019","journal-title":"Nanomedicine"},{"key":"10.1016\/j.ijpharm.2025.125293_b0190","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3390\/cancers10060207","article-title":"Hypersialylation in Cancer: Modulation of Inflammation and Therapeutic Opportunities","volume":"10","author":"Rodrigues","year":"2018","journal-title":"Cancers"},{"key":"10.1016\/j.ijpharm.2025.125293_b0195","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.xphs.2022.08.034","article-title":"Optimization and Appraisal of Chitosan-Grafted PLGA Nanoparticles for Boosting Pharmacokinetic and Pharmacodynamic Effect of Duloxetine HCl Using Box-Benkhen Design","volume":"112","author":"Salem","year":"2023","journal-title":"Journal of Pharmaceutical Sciences"},{"key":"10.1016\/j.ijpharm.2025.125293_b0200","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1021\/bm3018577","article-title":"Encapsulation of Antitumor Drug Doxorubicin and Its Analogue by Chitosan Nanoparticles","volume":"14","author":"Sanyakamdhorn","year":"2013","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.ijpharm.2025.125293_b0205","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/nature25016","article-title":"Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4","volume":"552","author":"Skrott","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.ijpharm.2025.125293_b0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2020.111452","article-title":"Disulfiram-loaded functionalized magnetic nanoparticles combined with copper and sodium nitroprusside in breast cancer cells","volume":"119","author":"Solak","year":"2021","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"key":"10.1016\/j.ijpharm.2025.125293_b0215","first-page":"377","article-title":"Stable loading and delivery of disulfiram with mPEG-PLGA\/PCL mixed nanoparticles for tumor therapy. Nanomedicine: Nanotechnology","volume":"12","author":"Song","year":"2016","journal-title":"Biology and Medicine"},{"key":"10.1016\/j.ijpharm.2025.125293_b0220","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1016\/j.ijbiomac.2017.08.057","article-title":"Size optimization and in vitro biocompatibility studies of chitosan nanoparticles","volume":"104","author":"Thandapani","year":"2017","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.ijpharm.2025.125293_bib278","doi-asserted-by":"crossref","DOI":"10.3389\/conf.fphar.2014.61.00009","article-title":"Evaluation of the role of pH in cancer cell proliferation","volume":"5","author":"Ujjal","year":"2014","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ijpharm.2025.125293_b0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2020.117497","article-title":"Phenylboronic acid-conjugated chitosan nanoparticles for high loading and efficient delivery of curcumin","volume":"256","author":"Wang","year":"2021","journal-title":"Carbohydr Polym"},{"key":"10.1016\/j.ijpharm.2025.125293_b0230","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.biomaterials.2013.10.028","article-title":"The combined effects of size and surface chemistry on the accumulation of boronic acid-rich protein nanoparticles in tumors","volume":"35","author":"Wang","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijpharm.2025.125293_b0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2013.02.019","article-title":"Size- and pathotropism-driven targeting and washout-resistant effects of boronic acid-rich protein nanoparticles for liver cancer regression","volume":"168","author":"Wang","year":"2013","journal-title":"J Control Release"},{"key":"10.1016\/j.ijpharm.2025.125293_b0240","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s13643-021-01858-4","article-title":"Anticancer effects of disulfiram: a systematic review of in vitro, animal, and human studies","volume":"11","author":"Wang","year":"2022","journal-title":"Systematic Reviews"},{"key":"10.1016\/j.ijpharm.2025.125293_b0245","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/s41401-019-0240-x","article-title":"Honokiol inhibits breast cancer cell metastasis by blocking EMT through modulation of Snail\/Slug protein translation","volume":"40","author":"Wang","year":"2019","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.ijpharm.2025.125293_b0250","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.7150\/thno.15156","article-title":"Phenylboronic Acid-Mediated Tumor Targeting of Chitosan Nanoparticles","volume":"6","author":"Wang","year":"2016","journal-title":"Theranostics"},{"key":"10.1016\/j.ijpharm.2025.125293_b0255","first-page":"641","article-title":"Poly lactic-co-glycolic acid controlled delivery of disulfiram to target liver cancer stem-like cells. Nanomedicine: Nanotechnology","volume":"13","author":"Wang","year":"2017","journal-title":"Biology and Medicine"},{"key":"10.1016\/j.ijpharm.2025.125293_b0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2023.122435","article-title":"A facile boronophenylalanine modified polydopamine dual drug-loaded nanoparticles for enhanced anti-tumor immune response in hepatocellular carcinoma comprehensive treatment","volume":"305","author":"Yang","year":"2024","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijpharm.2025.125293_b0265","doi-asserted-by":"crossref","first-page":"8117","DOI":"10.2147\/IJN.S353250","article-title":"Inhibition of Proliferation and Migration of Tumor Cells Through Phenylboronic Acid-Functionalized Polyamidoamine-Mediated Delivery of a Therapeutic DNAzyme Dz13 [Corrigendum]","volume":"16","author":"Yang","year":"2021","journal-title":"IJN"},{"key":"10.1016\/j.ijpharm.2025.125293_b0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.108727","article-title":"Disulfiram modulates ROS accumulation and overcomes synergistically cisplatin resistance in breast cancer cell lines","volume":"113","author":"Yang","year":"2019","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"07","key":"10.1016\/j.ijpharm.2025.125293_bib276","first-page":"740","article-title":"Effects of Folic Acid Coupling Rate on Targeted Resistance to Cancer Cells of Folic Acid-Chitosan Nanoparticles","volume":"38","author":"Yang","year":"2011","journal-title":"Cancer Research on Prevention and Treatment"},{"key":"10.1016\/j.ijpharm.2025.125293_b0275","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.carbpol.2015.12.032","article-title":"Controllable layer-by-layer assembly of PVA and phenylboronic acid-derivatized chitosan","volume":"140","author":"Zhang","year":"2016","journal-title":"Carbohydr Polym"}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517325001292?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517325001292?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:43:20Z","timestamp":1777337000000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517325001292"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":57,"alternative-id":["S0378517325001292"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2025.125293","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Disulfiram-Loaded PLGA nanoparticles modified with a Phenyl borate chitosan Conjugate enhance hepatic carcinoma treatment","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpharm.2025.125293","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"125293"}}